Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
Recruiting · NCT07208305 · Registry updated 2026-04-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting | Nausea, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Recruiting | Phase 3 | 2026-04-27 | NCT07208305 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Affiliated Hospital of Qinghai University | 22 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Qinghai University Affiliated Hospital | Xining | China | 16 |